Skip to main content

Zostavax News

Effectiveness of Live Zoster Vaccine Wanes Over Time

MONDAY, Dec. 11, 2023 – Live zoster vaccination is initially effective against outcomes, including herpes zoster and admission for herpes zoster, but the effectiveness wanes over time, according to...

Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk

MONDAY, Aug. 21, 2023 – Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals. Prior vaccination with the shingles...

CureVac’s Coronavirus Vaccine at the Center of a Fight for Control

CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...

Shingrix (zoster vaccine recombinant, adjuvanted) Approved in the U.S. for Prevention of Shingles

London UK 20 October 2017 – GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Zostavax patient information at Drugs.com